Skip to content
OpenCapital
Get started

Integra LifeSciences IART Q3 2025 earnings

Reported October 30, 2025 · Before market open

Revenue$402.1MMiss by $27.6M
EPS$0.54Beat by $0.11
Revenue estimate$429.6M
EPS estimate$0.43

Next report

Jul 29, 2026 (Today)
Revenue estimate$417.5M
EPS estimate$0.48
View report

Financials

Q3 2025

Income statement

See full
Revenue$402.1M+5.6%
Gross profit$207.0M+3.4%
Operating income$11.8M+244%
Net income-$5.4M+49.5%
EPS (diluted)-$0.07+50.0%

Balance sheet

See full
Cash & equivalents$232.2M+7.9%
Total debt$1.9B0.0%
Total equity$1.0B-31.8%
Total assets$3.6B-10.3%

Cash flow

See full
Operating cash flow$40.9M+81.9%
CapEx$15.2M-48.9%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.12B-20.6%
Enterprise value$2.81B-9.8%
P/S0.7×-0.2×

Profitability

See full
Gross margin52.3%-2.6pp
Operating margin-29.3%-31.1pp

Returns & leverage

See full
Debt / equity1.9×+0.6×
Current ratio3.1×+1.9×

Segments

By product

See full
Neurosurgery$201.6M+14.6%
Wound Reconstruction$84.0M+4.4%
Instruments$50.2M-7.5%
ENT$40.9M+0.7%
Private Label$25.5M-13.9%

By geography

See full
Europe$42.9M+24.8%
Asia Pacific$42.7M+15.2%
Rest of World$20.6M—

Versus estimates

Revenue

Q1 2026$391.9MBeat by $10.1MQ4 2025$434.9MBeat by $5.3M
Q3 2025$402.1MMiss by $27.6M
Q2 2025$415.6MBeat by $1.3MQ1 2025$382.7MMiss by $19.9MQ4 2024$442.6MBeat by $30.9M

Diluted EPS

Q1 2026$0.54Beat by $0.13Q4 2025$0.83Beat by $0.04
Q3 2025$0.54Beat by $0.11
Q2 2025$0.45Beat by $0.02Q1 2025$0.41Miss by $0.02Q4 2024$0.97Beat by $0.11

Ask the moment Integra LifeSciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Integra LifeSciences report Q3 2025 earnings?
Integra LifeSciences (IART) reported Q3 2025 earnings on October 30, 2025 before market open.
What were Integra LifeSciences's Q3 2025 revenue and EPS?
Integra LifeSciences reported revenue of $402.1M and eps of $0.54 for Q3 2025.
Did Integra LifeSciences beat estimates in Q3 2025?
Revenue missed the consensus estimate of $429.6M by $27.6M. EPS beat the consensus estimate of $0.43 by $0.11.
How did Integra LifeSciences's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.6% from $380.8M a year earlier and eps grew 31.7% from $0.41.
Where can I find Integra LifeSciences's Q3 2025 SEC filings?
You can read the 10-Q periodic report (0000917520-25-000096) directly on SEC EDGAR. The filing index links above go to sec.gov.